Acer Therapeutics Inc. (21)

Browse by Contract Category

Contracts

First Amendment, dated April 23, 2019, by and between Acer Therapeutics Inc. and Eastern Western Corp (Filed With SEC on August 10, 2021)
Exclusive License Agreement, dated as of April 4, 2014, by and between Acer Therapeutics Inc. and Baylor College of Medicine (Filed With SEC on May 17, 2021)
Collaboration and License Agreement, dated March 19, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on March 22, 2021)
Employment Agreement, dated February 1, 2021, by and between Acer Therapeutics Inc. and Jefferson E. Davis (Filed With SEC on March 1, 2021)
Security Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Lease Agreement, dated March 5, 2019, by and between Acer Therapeutics Inc. and Commonwealth Development LLC, as a trustee of the Gateway Realty Trust (Filed With SEC on August 13, 2019)
Agreement of Access and Use of Clinical Trial Data, dated as of August 3, 2016, by and between LAssistance Publique Hpitaux de Paris and Acer Therapeutics Inc (Filed With SEC on August 10, 2021)
Form of Notice of Stock Option Grant and Stock Option Agreement for option awards to be made under the 2018 Stock Incentive Plan (Filed With SEC on March 1, 2021)
Promissory Note, dated January 25, 2021, issued by Acer Therapeutics Inc. in favor of Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Option Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Exclusive License Agreement, dated as of December 21, 2018, by and between Acer Therapeutics Inc. and Sanofi (Filed With SEC on August 13, 2020)
Securities Purchase Agreement, dated July 24, 2020, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto (Filed With SEC on July 27, 2020)
Research Collaboration Agreement, dated March 26, 2020, by and between Acer Therapeutics Inc. and the National Center for Advancing Translational Sciences (Filed With SEC on June 1, 2020)
Registration Rights Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Purchase Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Amended and Restated Sales Agreement, dated March 18, 2020 by and among Acer Therapeutics Inc., Roth Capital Partners, LLC, and JonesTrading Institutional Services LLC (Filed With SEC on March 18, 2020)
Description of the Companys capital stock registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 18, 2020)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and Matthew T. Seibt (Filed With SEC on November 13, 2019)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and John Klopp (Filed With SEC on November 13, 2019)
Employment Agreement, dated December 4, 2018, by and between Acer Therapeutics Inc. and Salma Jutt-Eghbali (Filed With SEC on March 7, 2019)
Form of Notice of Restricted Stock Award for awards under the 2018 Stock Incentive Plan (Filed With SEC on March 7, 2019)